The extent of minimal residual disease reduction after the first 4-week imatinib therapy determines outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

The extent of minimal residual disease reduction after the first 4-week imatinib therapy determines outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia

Published:2009-02-01 Issue:3 Volume:115 Page:561-570
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Lee Seok,Kim Yoo-Jin,Chung Nak-Gyun,Lim Jihyang,Lee Dong-Gun,Kim Hee-Je,Min Chang-Ki,Lee Jong-Wook,Min Woo-Sung,Kim Chun-Choo

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference21 articles.

1. Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate;Thomas;Blood.,2004

2. Clinical effect of imatinib added to intensive combination chemotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia;Lee;Leukemia.,2005

3. High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia: a phase II study by the Japan Adult Leukemia Study Group;Yanada;J Clin Oncol.,2006

4. Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL);Wassmann;Blood.,2006

5. Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: results of the GRAAPH-2003 study;de Labarthe;Blood.,2007

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic and therapeutic advances in adults with acute lymphoblastic leukemia in the era of gene analysis and targeted immunotherapy;The Korean Journal of Internal Medicine;2024-01-01

2. Ponatinib vs. Imatinib as Frontline Treatment for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Matching Adjusted Indirect Comparison;Advances in Therapy;2023-05-19

3. MRD in ALL: Optimization and Innovations;Current Hematologic Malignancy Reports;2022-05-26

4. Improved outcome in children compared to adolescents and young adults after allogeneic hematopoietic stem cell transplant for acute myeloid leukemia: a retrospective study from the Francophone Society of Bone Marrow Transplantation and Cell Therapy (SFGM-TC);Journal of Cancer Research and Clinical Oncology;2021-09-04

5. Association of minimal residual disease with clinical outcomes in Philadelphia chromosome positive acute lymphoblastic leukemia in the tyrosine kinase inhibitor era: A systemic literature review and meta-analysis;PLOS ONE;2021-08-26